Skip to content

    Gujarat Fluorochemicals Limited

    FLUOROCHEM
    Chemicals·12 Feb 2026
    Management Summary

    Gujarat Fluorochemicals experienced a challenging Q3 FY26 with marginal revenue and EBITDA declines, primarily due to weakness in the refrigerant segment. However, the fluoropolymer segment showed robust growth, and the battery materials business made significant strategic progress with IFC and sovereign fund investments, and commercialization of LiPF6. The company anticipates improved conditions ahead, driven by tariff rationalization, R-32 production, and EV ESS adoption.

    Highlights

    5
    • Fluoropolymer segment delivered healthy growth of 14% YoY, driven by semicon and fluoroelastomer categories.

    • Recent reduction in U.S. tariffs from 50% to 18% provides significant relief and restores competitiveness in key export markets.

    • IFC approved investment of ₹430 crores in GFCL EV Products Limited, supporting India's first integrated battery materials manufacturing facility.

    • Another sovereign fund approved investment of $82 million in battery materials business, with documentation in process.

    • LiPF6 commercial supplies commenced in December 2025, with repeat orders received in Q4 FY26, and LFP plant operations stabilized with samples dispatched.

    Concerns

    6
    • Consolidated Revenue declined marginally by 1% YoY to ₹1,136 crores.

    • EBITDA declined by 6% to ₹275 crores from ₹294 crores in Q3 FY25.

    • Refrigerant portfolio faced significant headwinds, including R-22 production quota reduction, seasonally subdued demand, and weak R-125 prices.

    • Delay in R-32 production start-up resulted in lower-than-expected profitability, now pushed to Q4 FY26.

    • Fluorochemicals business revenue declined by 33% YoY and 24% sequentially.

    • Inventory levels increased to 201 days from an aspiration of 120 days due to cautious ordering and temporary deferment of demand.

    What Changed2

    vs Q4 FY26

    Guidance items6 → 11 (+5)Risks discussed2 → 5 (+3)
    Key financials

    Metrics

    3

    Periods

    2

    Headline

    2
    • Consolidated Revenue
      ₹1,136 Cr
      YoY-1%
    • EBITDA
      ₹275 Cr
      YoY-6%

    Q3 FY25

    1
    • EBITDA
      ₹294 Cr

    Segment breakdown

    Fluoropolymer
    14.0% Revenue Growth-0.03 sequential_decline Revenue Decline
    Fluorochemicals
    -33% Revenue Decline-0.24 sequential_decline Revenue Decline
    Bulk Chemicals
    Revenue Decline
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹6,000 crores

    M&A

    GFCL EV Products Limited (subsidiary)

    acquisition · Other · Consideration ₹NaN (other)

    M&A

    Battery materials business

    acquisition · announced · Consideration ₹NaN (other)

    Guidance & targets

    11
    CategoryTargetPriority
    Capacity
    R-32 Production Capacity (Phase 1)
    20,000 tonnes
    High
    Capacity
    R-32 Production Capacity (Long-term)
    30,000 tonnes
    High
    Capacity
    R-32 Quota Confirmation
    Confirmed
    High
    Working Capital
    Working Capital Days
    170-180 days
    Medium
    Revenue
    Battery Materials Revenue Growth
    Healthy revenue growth
    Medium
    Capacity Utilization
    Battery Materials (current capacity)
    Fully utilized
    High
    Capacity Utilization
    Battery Materials (overall capacity)
    Fully utilized
    High
    Commercialization
    Fluoropolymer Binders (PVDF)
    Commercial operations
    High
    Commercialization
    LFP Cathode Active Material
    Commercial supply
    Medium
    Commercialization
    R-32 Sales Ramp-up
    Start from Q4
    High
    Commercialization
    Electrolyte Business
    Start by end of coming financial year
    Medium

    What to watch in Q4 FY26

    5

    R-32 Production Ramp-up

    Q4 FY26
    CurrentProduction started, ramping up
    TargetSignificant sales ramp-up

    Why it matters

    R-32 is a key value creator and its successful ramp-up is crucial for the refrigerant segment's recovery and overall profitability.

    Also, the value creator for us this year going forward in this segment will be R-32 sales ramp-up, which we are expecting to start from Quarter 3, which has now been pushed to Quarter 4.

    Risks & concerns

    5
    RiskSeverity

    Weakness in refrigerant segment

    Impacted by R-22 production quota reduction, seasonally subdued demand, and weak R-125 prices.Management acknowledged

    high

    Delay in R-32 production start-up

    Pushed from Q3 to Q4 FY26, impacting expected profitability.Management acknowledged

    high

    Inventory buildup

    Increased to 201 days due to seasonal weakness, holiday season, and tariff uncertainty, though off-take has started.Management acknowledged

    medium

    Long qualification times for EV/ESS products

    Delays commercialization and revenue ramp-up for new battery materials products.Management acknowledged

    medium

    Antidumping duty not approved for PTFE

    Eroded expected growth in PTFE domestic market, requiring relocation to other markets.Management acknowledged

    medium

    Q&A highlights

    8

    “Our plan is to still commission going to 20,000 tonnes, as I had indicated earlier. Of course, at that time, I had indicated it was going to be March end. Now I expect that to be slightly delayed by a quarter or maybe a quarter and a half, okay? ... The capacity can be added up to December 2027, okay? Of course, in the previous call also I had indicated that the long-term plan is to go to 30,000 tonnes, or go up to our quota that we have today.”

    Clarifies the revised timeline for R-32 capacity commissioning and the long-term capacity target, which is a key growth driver.

    asked by Sanjesh Jain

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 FY26 Performance Overview and Headwinds

    Gujarat Fluorochemicals reported a challenging Q3 FY26, with consolidated revenue marginally declining by 1% YoY to ₹1,136 crores. EBITDA also saw a 6% decline, reaching ₹275 crores compared to ₹294 crores in Q3 FY25. This performance was primarily attributed to seasonal weakness in the refrigerant segment, holiday seasons in Europe and the U.S., and continued uncertainty around U.S. tariff policies, which impacted both volumes and realizations.

    02

    Refrigerant Segment Challenges and Outlook

    The refrigerant portfolio bore the brunt of multiple headwinds, with the most adverse pressure coming from R-22 due to production quota reductions and subdued demand. The delay in R-32 production start-up further impacted profitability, now expected to commence in Q4 FY26. R-125 prices also remained weak. However, management expects improved profitability in coming quarters as seasonal demand normalizes and R-32 sales ramp up, with the first phase targeting 20,000 tonnes capacity, eventually reaching 30,000 tonnes by December 2027.

    03

    Fluoropolymer Segment Resilience and Growth Drivers

    Despite overall challenges, the Fluoropolymer segment delivered healthy 14% YoY growth, though it saw a 3% sequential decline due to U.S. tariff policy uncertainty. The recent reduction in U.S. tariffs from 50% to 18% is expected to provide significant relief and restore competitiveness. The company anticipates strong momentum, particularly from the semiconductor industry, and is gaining market share from legacy players in elastomers and other fluoropolymers, with new grades under qualification.

    04

    Battery Materials: Strategic Investments and Commercialization Progress

    The battery materials business is a key strategic focus, attracting significant investments. IFC approved ₹430 crores in GFCL EV Products Limited, and another sovereign fund approved $82 million. The company is setting up a $216 million greenfield advanced battery materials project in Oman. LiPF6 commercial supplies commenced in December 2025, with repeat orders in Q4 FY26. The LFP cathode active material plant has stabilized operations, with sample dispatches and qualification progressing, and fluoropolymer binders are expected to begin commercial operations in H1 FY27.

    05

    Capital Allocation and Funding for Growth

    The company has already invested approximately ₹1,700 crores in battery chemical assets. The Oman project, estimated at $216 million, is part of the larger ₹6,000 crores CAPEX plan for battery materials. The IFC and sovereign fund investments are structured as convertible instruments linked to IPO milestones, providing funding without fixed valuation. Management aims to reduce working capital days from the current 201 to 170-180 days within a year.

    06

    Outlook and Future Strategy

    Management expressed confidence in improving conditions ahead, driven by tariff rationalization, R-32 production, and faster EV ESS adoption. The company remains focused on execution, cost discipline, and responsible scaling of new growth platforms. The outlook for FY27 includes healthy revenue growth from battery materials, with current capacities expected to be fully utilized by the end of 2026, and overall capacity by 2027-2028.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.